Short-Acting β₂-Agonist Use Could Be a Confounding Factor for Interpreting Increased IL-6.

ABSTRACT:

SUBMITTER: Nannini LJ 

PROVIDER: S-EPMC7605194 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature